178 related articles for article (PubMed ID: 38474258)
1. Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.
Tsang HF; Pei XM; Wong YKE; Wong SCC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474258
[TBL] [Abstract][Full Text] [Related]
2. Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study.
Chao S; Ying J; Liew G; Marshall W; Liew CC; Burakoff R
J Exp Clin Cancer Res; 2013 Jul; 32(1):44. PubMed ID: 23876008
[TBL] [Abstract][Full Text] [Related]
3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
4. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.
Xue VW; Ng SSM; Tsang HF; Wong HT; Leung WW; Wong YN; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Tai WCS; Wong SCC
Clin Exp Med; 2023 Oct; 23(6):2421-2432. PubMed ID: 36637582
[TBL] [Abstract][Full Text] [Related]
5. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
6. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis.
Lotfi E; Kholghi A; Golab F; Mohammadi A; Barati M
Pathol Res Pract; 2024 Mar; 255():155187. PubMed ID: 38377721
[TBL] [Abstract][Full Text] [Related]
9. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
[TBL] [Abstract][Full Text] [Related]
11. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.
Larrinaga G; Perez I; Sanz B; Beitia M; Errarte P; Fernández A; Blanco L; Etxezarraga MC; Gil J; López JI
PLoS One; 2015; 10(3):e0119436. PubMed ID: 25790122
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface markers for colon adenoma and adenocarcinoma.
Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
[TBL] [Abstract][Full Text] [Related]
14. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
[TBL] [Abstract][Full Text] [Related]
15. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
16. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
Moshayoff V; Faktor O; Laghi L; Celesti G; Peretz T; Keret D; Cohen D; Israeli E
PLoS One; 2016; 11(7):e0159522. PubMed ID: 27441409
[TBL] [Abstract][Full Text] [Related]
18. Plasma miRNA can detect colorectal cancer, but how early?
Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I
Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205
[TBL] [Abstract][Full Text] [Related]
19. Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer.
Effendi-Ys R
Acta Med Indones; 2022 Jul; 54(3):476-486. PubMed ID: 36156476
[TBL] [Abstract][Full Text] [Related]
20. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
